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Background: Aortic valve stenosis (AS) occurs with increased frequency in hemodialysis (HD) patients and could contribute to the excess 
cardiovascular mortality. However, little is known about differences in progression of the AS process between HD and non-HD patients. Neopterin, 
a by-product of the guanosine triphosphate pathway, is produced by activated macrophages on stimulation by interferon-a from T-lymphocytes and 
is capable of enhancing the oxidative potential of reactive oxygen species. To elucidate the role of neopterin in the aortic valve of AS patients with 
HD, we used immunostaining to identify neopterin in aortic valve specimens from AS patients with and without HD. Furthermore, we investigated the 
association between neopterin in aortic valve specimens and plasma neopterin levels in AS patients with and without HD.
Methods: Frozen aortic valve samples were surgically obtained from a cohort of 43 AS patients with HD (n=18) and without HD (n=25). 
Immunostaining of the samples was performed with antibodies against smooth muscle cells, macrophages, T-lymphocytes, neutrophils, microvessels 
and neopterin. In addition, venous blood samples were obtained from 30 control subjects and 38 of the 43 AS patients, and plasma neopterin levels 
were measured using HPLC.
Results: The neopterin-positive area, as a percentage of the total area, was significantly higher in patients with than without HD (P<0.0001). 
Moreover, the percentage of the neopterin-positive area was positively correlated with the number of neutrophils and T-lymphocytes (neutrophils, r 
= 0.77, P<0.0001; T-lymphocytes, r = 0.78, P<0.0001). Plasma neopterin levels were significantly higher in AS patients without HD than in control 
subjects (P<0.0001). In addition, plasma neopterin levels were significantly higher in AS patients with than without HD (P<0.0001). Plasma 
neopterin levels were positively correlated with the neopterin-positive area in aortic valve specimens in AS patients (r=0.73, P<0.0001).
Conclusion: This study demonstrated that increased expression and plasma levels of neopterin may be one of the mechanisms responsible for 
rapid progression of AS in HD patients.
